Literature DB >> 2302834

Anti-endothelial cell antibodies in patients with Wegener's granulomatosis and micropolyarteritis.

G Ferraro1, P L Meroni, A Tincani, A Sinico, W Barcellini, A Radice, G Gregorini, M Froldi, M O Borghi, G Balestrieri.   

Abstract

Anti-endothelial cell antibodies (AECA) have been detected by cell surface radioimmunoassay in nine out of 15 patients with micropolyarteritis (MPA) and in two out of five patients with Wegener's granulomatosis. AECA mostly belonged to the IgG isotype and were present in the active phase of the diseases. These antibodies were not detectable in 10 sera from patients with essential mixed cryoglobulinaemia, suggesting that they were not a mere epiphenomenon consequent to the inflammatory vascular injury. The binding activity was not related to ABH antigens or to HLA class I antigens displayed by resting human endothelial cells in culture and was not influenced by removing immune complexes. Absorption of the anti-neutrophil cytoplasmic antibodies (ANCA), present in MPA and Wegener's granulomatosis sera, did not affect the endothelial binding. AECA-positive sera did not display lytic activity against endothelial cells, neither alone nor after addition of fresh complement or normal human peripheral blood mononuclear cells. Although AECA are not cytolytic for endothelial cell monolayers in vitro, the reactivity against intact endothelial cells suggests their possible involvement in in vivo pathological processes affecting vascular structures in small vessel primary vasculitides.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2302834      PMCID: PMC1534732          DOI: 10.1111/j.1365-2249.1990.tb05125.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  25 in total

1.  A new antigen system expressed in human endothelial cells.

Authors:  J R Moraes; P Stastny
Journal:  J Clin Invest       Date:  1977-08       Impact factor: 14.808

2.  The spectrum of vasculitis: clinical, pathologic, immunologic and therapeutic considerations.

Authors:  A S Fauci; B Haynes; P Katz
Journal:  Ann Intern Med       Date:  1978-11       Impact factor: 25.391

3.  Effect of corticosteroids on neutrophil function: inhibition of antibody-dependent cell mediated cytotoxicity (ADCC).

Authors:  F Capsoni; P L Meroni; M R Zocchi; A M Plebani; M Vezio
Journal:  J Immunopharmacol       Date:  1983

4.  Cultured human endothelial cells display an antigen that is recognized by certain human anti-chromatin autoantibodies.

Authors:  M Horneland; O P Rekvig; L Jørgensen; K Hannestad
Journal:  Clin Exp Immunol       Date:  1983-11       Impact factor: 4.330

5.  Synthesis and release of factor VIII by cultured human endothelial cells.

Authors:  E G Tuddenham; J Lazarchick; L W Hoyer
Journal:  Br J Haematol       Date:  1981-04       Impact factor: 6.998

6.  Biologic and clinical significance of cryoglobulins. A report of 86 cases.

Authors:  J C Brouet; J P Clauvel; F Danon; M Klein; M Seligmann
Journal:  Am J Med       Date:  1974-11       Impact factor: 4.965

7.  Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria.

Authors:  E A Jaffe; R L Nachman; C G Becker; C R Minick
Journal:  J Clin Invest       Date:  1973-11       Impact factor: 14.808

8.  Autoantibodies to glomerular antigens in patients with Wegener's granulomatosis.

Authors:  F Abbott; S Jones; C M Lockwood; A J Rees
Journal:  Nephrol Dial Transplant       Date:  1989       Impact factor: 5.992

Review 9.  Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years.

Authors:  A S Fauci; B F Haynes; P Katz; S M Wolff
Journal:  Ann Intern Med       Date:  1983-01       Impact factor: 25.391

10.  Increased factor VIII/von Willebrand factor antigen and von Willebrand factor activity in scleroderma and in Raynaud's phenomenon.

Authors:  M B Kahaleh; I Osborn; E C LeRoy
Journal:  Ann Intern Med       Date:  1981-04       Impact factor: 25.391

View more
  28 in total

Review 1.  Role of proteinase 3 in activation of endothelium.

Authors:  M E Taekema-Roelvink; C van Kooten; C A Verburgh; M R Daha
Journal:  Springer Semin Immunopathol       Date:  2001

2.  Peroxiredoxin 2 is a novel autoantigen for anti-endothelial cell antibodies in systemic vasculitis.

Authors:  R Karasawa; M S Kurokawa; K Yudoh; K Masuko; S Ozaki; T Kato
Journal:  Clin Exp Immunol       Date:  2010-09       Impact factor: 4.330

Review 3.  Primary and secondary vasculitic neuropathy.

Authors:  Gérard Said; Catherine Lacroix
Journal:  J Neurol       Date:  2005-04-05       Impact factor: 4.849

Review 4.  Clinical immunology.

Authors:  R J Powell
Journal:  Postgrad Med J       Date:  1991-11       Impact factor: 2.401

5.  Vascular damage in Wegener's granulomatosis and microscopic polyarteritis: presence of anti-endothelial cell antibodies and their relation to anti-neutrophil cytoplasm antibodies.

Authors:  C O Savage; B E Pottinger; G Gaskin; C M Lockwood; C D Pusey; J D Pearson
Journal:  Clin Exp Immunol       Date:  1991-07       Impact factor: 4.330

Review 6.  New horizons in renal vasculitis.

Authors:  J S Cameron
Journal:  Klin Wochenschr       Date:  1991-09-03

7.  Binding of proteinase 3 and myeloperoxidase to endothelial cells: ANCA-mediated endothelial damage through ADCC?

Authors:  B E Ballieux; K T Zondervan; P Kievit; E C Hagen; L A van Es; F J van der Woude; M R Daha
Journal:  Clin Exp Immunol       Date:  1994-07       Impact factor: 4.330

8.  Antibodies to endothelial cells in Behçet's disease: cell-binding heterogeneity and association with clinical activity.

Authors:  R Cervera; M Navarro; A López-Soto; M C Cid; J Font; J Esparza; J C Reverter; J Monteagudo; M Ingelmo; A Urbano-Márquez
Journal:  Ann Rheum Dis       Date:  1994-04       Impact factor: 19.103

9.  A western blot assay detects autoantibodies to cryptic endothelial antigens in thrombotic microangiopathies.

Authors:  D W Koenig; L Barley-Maloney; T O Daniel
Journal:  J Clin Immunol       Date:  1993-05       Impact factor: 8.317

10.  Anti-endothelial cell antibodies in nephropathia epidemica and other viral diseases.

Authors:  A G Wangel; M Temonen; M Brummer-Korvenkontio; A Vaheri
Journal:  Clin Exp Immunol       Date:  1992-10       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.